Elite Diagnostic Balance Sheet Health
Financial Health criteria checks 1/6
Elite Diagnostic has a total shareholder equity of JMD499.5M and total debt of JMD342.6M, which brings its debt-to-equity ratio to 68.6%. Its total assets and total liabilities are JMD1.0B and JMD537.6M respectively. Elite Diagnostic's EBIT is JMD85.5M making its interest coverage ratio 1.9. It has cash and short-term investments of JMD45.9M.
Key information
68.6%
Debt to equity ratio
JA$342.56m
Debt
| Interest coverage ratio | 1.9x |
| Cash | JA$45.88m |
| Equity | JA$499.54m |
| Total liabilities | JA$537.59m |
| Total assets | JA$1.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ELITE's short term assets (JMD195.7M) do not cover its short term liabilities (JMD235.4M).
Long Term Liabilities: ELITE's short term assets (JMD195.7M) do not cover its long term liabilities (JMD302.2M).
Debt to Equity History and Analysis
Debt Level: ELITE's net debt to equity ratio (59.4%) is considered high.
Reducing Debt: ELITE's debt to equity ratio has increased from 42% to 68.6% over the past 5 years.
Debt Coverage: ELITE's debt is well covered by operating cash flow (46.7%).
Interest Coverage: ELITE's interest payments on its debt are not well covered by EBIT (1.9x coverage).